Days after US regulators gave the AstraZeneca-Oxford vaccine the green light to re-start its US-based trials, the FT is reporting new data that seems promising, even if it’s still pretty preliminary.
— Read on www.zerohedge.com/geopolitical/astrazeneca-says-its-covid-19-vaccine-produces-robust-immune-response-elderly-patients
news, current events, commentary, politics, history, opinion, minecraft, digital currency, beer